TI
TEVA icon

Tidal Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Tidal Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-31,400
Closed -$980K – 2578
2025
Q4 		$980K Buy
+31,400
New +$774K ﹤0.01% 1279

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tidal Investments's TEVA Position: Q1 2026 in Review

Tidal Investments increased its Teva Pharmaceuticals (TEVA) stake by 33% in Q1 2026, buying an estimated $789K and bringing the position to 99,173 shares worth $2.99M. The position accounts for 0.01% of the portfolio, ranked #1000.

Tidal Investments first reported a position in TEVA in Q2 2024 and has held it in 5 quarters since. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Tidal Investments held 99,173 shares of Teva Pharmaceuticals worth $2.99M as of Q1 2026.
  • Tidal Investments bought 24,533 Teva Pharmaceuticals shares in Q1 2026, an estimated $789K.
  • Teva Pharmaceuticals made up 0.01% of Tidal Investments's portfolio in Q1 2026, its #1000 holding.
  • Tidal Investments first reported a position in Teva Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.